Skip to main content
Premium Trial:

Request an Annual Quote

Manuel Glynias, Bill Blake, Ed Zander, Richard Woychik

Premium

NetGenics founder and former CEO Manuel Glynias has left Lion Biosciences, where he was serving as senior vice president for strategic planning following Lion’s acquisition of Netgenics in January.

A Lion spokesperson said Glynias’ departure was a “friendly and mutual decision.”

 

Bill Blake, formerly vice president of high performance technical computing at Compaq (now Hewlett-Packard), will be leaving the company at the end of June. He will join Framingham, Mass.-based database and data-mining startup Netezza as senior vice president of product development. “One of my goals is to help them bring their products to the bioinformatics marketplace,” said Blake of his new employer.

In May, Ed Zander, president and COO of Sun Microsystems, joined Netezza’s board of directors.

 

Richard Woychik, currently CSO of Hayward, Calif.-based Lynx Therapeutics, has been tapped as the new director of the Jackson Laboratory in Bar Harbor, Maine. He will assume his new role at the Jackson Lab in August and will continue to serve on Lynx’s board of directors.

Filed under

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.